Grace Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3.9M Buy
14,118
+200
+1% +$50.7K 2.32% 9
2021
Q3
$3.41M Hold
13,918
2.1% 11
2021
Q2
$3.19M Hold
13,918
2.14% 10
2021
Q1
$2.6M Buy
13,918
+3,400
+32% +$665K 1.65% 12
2020
Q4
$1.78M Hold
10,518
1.12% 20
2020
Q3
$1.56M Hold
10,518
1.21% 18
2020
Q2
$1.73M Hold
10,518
1.48% 14
2020
Q1
$1.46M Sell
10,518
-10,000
-49% -$1.37M 1.43% 17
2019
Q4
$2.7M Buy
+20,518
New +$2.38M 2.2% 6

Other funds holding LLY

Grace Capital's LLY Position: Q4 2021 in Review

Grace Capital increased its Eli Lilly (LLY) stake by 1.4% in Q4 2021, buying an estimated $50.7K and bringing the position to 14,118 shares worth $3.9M. The position accounts for 2.32% of the portfolio, ranked #9.

Grace Capital first reported a position in LLY in Q4 2019 and has held it in 9 quarters since. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Grace Capital held 14,118 shares of Eli Lilly worth $3.9M as of Q4 2021.
  • Grace Capital bought 200 Eli Lilly shares in Q4 2021, an estimated $50.7K.
  • Eli Lilly made up 2.32% of Grace Capital's portfolio in Q4 2021, its #9 holding.
  • Grace Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 9 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.